Milestones :: Perspectives :: Research

COVID-19 Vaccines :: Development/Procurement/Distribution/Logistics

Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
December 18, 2020

European Commission Exercises Option for Additional 80 Million Doses of Moderna’s COVID-19 Vaccine Candidate
December 14, 2020

U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older
December 14, 2020

Codagenix and Serum Institute of India Announce Commencement of First-in-Human Trial of COVI-VAC, A Single Dose, Intranasal Live Attenuated Vaccine for COVID-19
Dec 14, 2020, 08:00
– Randomized, double-blind, placebo-controlled, dose-escalation trial
– 48 volunteers to be enrolled at three dose levels
– Endpoints include safety, tolerability and immunogenicity

::::::

Reuters
Health News
December 14, 20204:19 AM Updated 5 days ago
Singapore approves Pfizer’s COVID-19 vaccine in Asia first
By John Geddie, Anshuman Daga
SINGAPORE (Reuters) – Singapore became on Monday the first Asian country to approve Pfizer-BioNTech’s coronavirus vaccine and said it expects to start receiving shots by the end of the year.

Reuters
COVID-19 Pandemic
Saudi Arabia Begins Inoculating People With Pfizer COVID-19 Vaccines
December 17, 2020 11:07 AM

Reuters
Middle East & Africa
December 11, 20203:45 PM Updated 8 days ago
WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks
GENEVA (Reuters) – The World Health Organization expects to make decisions on whether to give emergency use approval to COVID-19 vaccines from Pfizer, Moderna and AstraZeneca in the coming weeks, its chief scientist said on Friday.